MEK2 regulates ribonucleotide reductase activity through functional interaction with ribonucleotide reductase small subunit p53R2

Cell Cycle

Volumn 11, Issue 17, 2012, Pages 3237-3249

  Piao, Chunmei ^a   Youn, Cha Kyung ^a   Jin, Min ^a,b   Yoon, Sang Pil ^c   Chang, In Youb ^a   Lee, Jung Hee ^a   You, Ho Jin ^a  

^a Chosun University   (South Korea)

^b YANBIAN UNIVERSITY   (China)

^c Jeju National University School of Medicine   (South Korea)

Author keywords

DNA damage repair; Ionizing radiation; MEK2; p53R2; Ribonucleotide reductase

Indexed keywords

AMINO ACID; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; OXIDOREDUCTASE; RIBONUCLEOTIDE REDUCTASE; RIBONUCLEOTIDE REDUCTASE SMALL SUBUNIT P53R2; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INHIBITION KINETICS; IONIZING RADIATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 84866290837     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.21591     Document Type: Article

References (42)

1. Eklund H, Uhlin U, Färnegårdh M, Logan DT, Nordlund P. Structure and function of the radical enzyme ribonucleotide reductase. Prog Biophys Mol Biol 2001; 77:177-268; PMID:11796141; http://dx.doi.org/10.1016/ S0079-6107(01)00014-1
2. Nordlund P, Reichard P. Ribonucleotide reductases. Annu Rev Biochem 2006; 75:681-706; PMID:16756507; http://dx.doi.org/10.1146/annurev.biochem.75.103004. 142443
3. Thelander L, Reichard P. Reduction of ribonucleotides. Annu Rev Biochem 1979; 48:133-58; PMID:382982; http://dx.doi.org/10.1146/annurev.bi.48.070179. 001025
4. Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S, Matsui K, et al. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 2000; 404:42-9; PMID:10716435; http://dx.doi.org/10.1038/35003506
5. Yamaguchi T, Matsuda K, Sagiya Y, Iwadate M, Fujino MA, Nakamura Y, et al. p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint. Cancer Res 2001; 61:8256-62; PMID:11719458
6. Nakano K, Bálint E, Ashcroft M, Vousden KH. A ribonucleotide reductase gene is a transcriptional target of p53 and p73. Oncogene 2000; 19:4283-9; PMID:10980602; http://dx.doi.org/10.1038/sj.onc.1203774
7. Chabes AL, Pfleger CM, Kirschner MW, Thelander L. Mouse ribonucleotide reductase R2 protein: a new target for anaphase-promoting complex-Cdh1-mediated proteolysis. Proc Natl Acad Sci USA 2003; 100:3925-9; PMID:12655059; http://dx.doi.org/10.1073/pnas.0330774100
8. Dhillon AS, Hagan S, Rath O, Kolch W. MAP kinase signalling pathways in cancer. Oncogene 2007; 26:3279-90; PMID:17496922; http://dx.doi.org/10.1038/sj. onc.1210421
9. Abbott DW, Holt JT. Mitogen-activated protein kinase kinase 2 activation is essential for progression through the G2/M checkpoint arrest in cells exposed to ionizing radiation. J Biol Chem 1999; 274:2732-42; PMID:9915804; http://dx.doi.org/10.1074/jbc.274.5.2732
10. Cui W, Yazlovitskaya EM, Mayo MS, Pelling JC, Persons DL. Cisplatin-induced response of c-jun N-terminal kinase 1 and extracellular signal-regulated protein kinases 1 and 2 in a series of cisplatinresistant ovarian carcinoma cell lines. Mol Carcinog 2000; 29:219-28; PMID:11170260; http://dx.doi.org/10.1002/1098-2744(200012)29:4〈219::AIDMC1004〉3.0. CO;2-D
11. Wang X, McGowan CH, Zhao M, He L, Downey JS, Fearns C, et al. Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest. Mol Cell Biol 2000; 20:4543-52; PMID:10848581; http://dx.doi.org/10.1128/MCB.20.13. 4543-4552.2000
12. Yan Y, Black CP, Cowan KH. Irradiation-induced G2/M checkpoint response requires ERK1/2 activation. Oncogene 2007; 26:4689-98; PMID:17297454; http://dx.doi.org/10.1038/sj.onc.1210268
13. Yan Y, Black CP, Cao PT, Haferbier JL, Kolb RH, Spieker RS, et al. Gamma-irradiation-induced DNA damage checkpoint activation involves feedback regulation between extracellular signal-regulated kinase 1/2 and BRCA1. Cancer Res 2008; 68:5113-21; PMID:18593910; http://dx.doi.org/10.1158/0008-5472.CAN-07- 5818
14. Carter S, Auer KL, Reardon DB, Birrer M, Fisher PB, Valerie K, et al. Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells. Oncogene 1998; 16:2787-96; PMID:9652746; http://dx.doi.org/10.1038/sj. onc.1201802
15. Wright JH, Munar E, Jameson DR, Andreassen PR, Margolis RL, Seger R, et al. Mitogen-activated protein kinase kinase activity is required for the G(2)/M transition of the cell cycle in mammalian fibroblasts. Proc Natl Acad Sci USA 1999; 96:11335-40; PMID:10500177; http://dx.doi.org/10.1073/pnas.96.20.11335
16. Abrams SL, Steelman LS, Shelton JG, Wong EW, Chappell WH, Bäsecke J, et al. The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy. Cell Cycle 2010; 9:1781-91; PMID:20436278; http://dx.doi.org/10.4161/cc.9.9.11483
17. Steelman LS, Abrams SL, Shelton JG, Chappell WH, Bäsecke J, Stivala F, et al. Dominant roles of the Raf/ MEK/ERK pathway in cell cycle progression, prevention of apoptosis and sensitivity to chemotherapeutic drugs. Cell Cycle 2010; 9:1629-38; PMID:20372086; http://dx.doi.org/10.4161/cc.9.8.11487
18. Steelman LS, Navolanic P, Chappell WH, Abrams SL, Wong EW, Martelli AM, et al. Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells. Cell Cycle 2011; 10:3003-15; PMID:21869603; http://dx.doi.org/10.4161/cc.10.17.17119
19. Golding SE, Rosenberg E, Neill S, Dent P, Povirk LF, Valerie K. Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response. Cancer Res 2007; 67:1046-53; PMID:17283137; http://dx.doi.org/10.1158/0008-5472.CAN-06- 2371
20. Khalil A, Morgan RN, Adams BR, Golding SE, Dever SM, Rosenberg E, et al. ATM-dependent ERK signaling via AKT in response to DNA double-strand breaks. Cell Cycle 2011; 10:481-91; PMID:21263216; http://dx.doi.org/10.4161/cc.10.3. 14713
21. Tang D, Wu D, Hirao A, Lahti JM, Liu L, Mazza B, et al. ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. J Biol Chem 2002; 277:12710-7; PMID:11821415; http://dx.doi.org/10.1074/jbc. M111598200
22. Fang L, Li G, Liu G, Lee SW, Aaronson SA. p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades. EMBO J 2001; 20:1931-9; PMID:11296226; http://dx.doi.org/10.1093/emboj/20.8.1931
23. Lee SW, Fang L, Igarashi M, Ouchi T, Lu KP, Aaronson SA. Sustained activation of Ras/Raf/mitogen-activated protein kinase cascade by the tumor suppressor p53. Proc Natl Acad Sci USA 2000; 97:8302-5; PMID:10890907; http://dx.doi.org/10.1073/pnas.150024397
24. Guittet O, Håkansson P, Voevodskaya N, Fridd S, Gräslund A, Arakawa H, et al. Mammalian p53R2 protein forms an active ribonucleotide reductase in vitro with the R1 protein, which is expressed both in resting cells in response to DNA damage and in proliferating cells. J Biol Chem 2001; 276:40647-51; PMID:11517226; http://dx.doi.org/10.1074/jbc.M106088200
25. Lozano G, Elledge SJ. p53 sends nucleotides to repair DNA. Nature 2000; 404:24-5; PMID:10716425; http://dx.doi.org/10.1038/35003670
26. Tsai MH, Chen X, Chandramouli GV, Chen Y, Yan H, Zhao S, et al. Transcriptional responses to ionizing radiation reveal that p53R2 protects against radiation-induced mutagenesis in human lymphoblastoid cells. Oncogene 2006; 25:622-32; PMID:16247478
27. Håkansson P, Hofer A, Thelander L. Regulation of mammalian ribonucleotide reduction and dNTP pools after DNA damage and in resting cells. J Biol Chem 2006; 281:7834-41; PMID:16436374; http://dx.doi.org/10.1074/jbc. M512894200
28. Lebedeva MA, Shadel GS. Cell cycle- and ribonucleotide reductase-driven changes in mtDNA copy number influence mtDNA Inheritance without compromising mitochondrial gene expression. Cell Cycle 2007; 6:2048-57; PMID:17721079; http://dx.doi.org/10.4161/cc.6.16.4572
29. Bourdon A, Minai L, Serre V, Jais JP, Sarzi E, Aubert S, et al. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat Genet 2007; 39:776-80; PMID:17486094; http://dx.doi.org/10.1038/ng2040
30. Harper JW, Elledge SJ. The DNA damage response: ten years after. Mol Cell 2007; 28:739-45; PMID:18082599; http://dx.doi.org/10.1016/j.molcel.2007.11.015
31. Bartek J, Lukas J. DNA damage checkpoints: from initiation to recovery or adaptation. Curr Opin Cell Biol 2007; 19:238-45; PMID:17303408; http://dx.doi.org/10.1016/j.ceb.2007.02.009
32. Yan Y, Spieker RS, Kim M, Stoeger SM, Cowan KH. BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation. Oncogene 2005; 24:3285-96; PMID:15735702; http://dx.doi.org/10.1038/sj.onc.1208492
33. Chabes A, Georgieva B, Domkin V, Zhao X, Rothstein R, Thelander L. Survival of DNA damage in yeast directly depends on increased dNTP levels allowed by relaxed feedback inhibition of ribonucleotide reductase. Cell 2003; 112:391-401; PMID:12581528; http://dx.doi.org/10.1016/S0092-8674(03)00075-8
34. Holmberg C, Fleck O, Hansen HA, Liu C, Slaaby R, Carr AM, et al. Ddb1 controls genome stability and meiosis in fission yeast. Genes Dev 2005; 19:853-62; PMID:15805471; http://dx.doi.org/10.1101/gad.329905
35. Eaton JS, Lin ZP, Sartorelli AC, Bonawitz ND, Shadel GS. Ataxia-telangiectasia mutated kinase regulates ribonucleotide reductase and mitochondrial homeostasis. J Clin Invest 2007; 117:2723-34; PMID:17786248; http://dx.doi.org/10.1172/JCI31604
36. Naruyama H, Shimada M, Niida H, Zineldeen DH, Hashimoto Y, Kohri K, et al. Essential role of Chk1 in S phase progression through regulation of RNR2 expression. Biochem Biophys Res Commun 2008; 374:79-83; PMID:18616928; http://dx.doi.org/10.1016/j.bbrc.2008.06.112
37. Zhang YW, Jones TL, Martin SE, Caplen NJ, Pommier Y. Implication of checkpoint kinase-dependent upregulation of ribonucleotide reductase R2 in DNA damage response. J Biol Chem 2009; 284:18085-95; PMID:19416980; http://dx.doi.org/10.1074/jbc.M109.003020
38. Xue L, Zhou B, Liu X, Qiu W, Jin Z, Yen Y. Wildtype p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits. Cancer Res 2003; 63:980-6; PMID:12615712
39. Chang L, Zhou B, Hu S, Guo R, Liu X, Jones SN, et al. ATM-mediated serine 72 phosphorylation stabilizes ribonucleotide reductase small subunit p53R2 protein against MDM2 to DNA damage. Proc Natl Acad Sci USA 2008; 105:18519-24; PMID:19015526; http://dx.doi.org/10.1073/pnas.0803313105
40. Lee YD, Wang J, Stubbe J, Elledge SJ. Dif1 is a DNA-damage-regulated facilitator of nuclear import for ribonucleotide reductase. Mol Cell 2008; 32:70-80; PMID:18851834; http://dx.doi.org/10.1016/j.molcel.2008.08.018
41. Piao C, Jin M, Kim HB, Lee SM, Amatya PN, Hyun JW, et al. Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2. Oncogene 2009; 28:2173-84; PMID:19398949; http://dx.doi.org/10.1038/ onc.2009.84
42. Fukushima M, Fujioka A, Uchida J, Nakagawa F, Takechi T. Thymidylate synthase (TS) and ribonucleotide reductase (RNR) may be involved in acquired resistance to 5-fluorouracil (5-FU) in human cancer xenografts in vivo. Eur J Cancer 2001; 37:1681-7; PMID:11527696; http://dx.doi.org/10.1016/S0959-8049(01) 00174-5